Whether you're shopping for a holistic health connoisseur or a fitness enthusiast or, our editors' favorite picks have you covered for Valentine's Day.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
Victims of the L.A. County firestorms are grieving their losses as well as frustrated with delays in getting restarted with their lives, which L.A. police say makes ...